CD8A and neoplasm: These results validate that LLL exposure to both dLNs and tumor enhances the functionality of tumor‐infiltrating CD8+ T cells, thereby providing a compelling rationale for the combined use of LLL with nanoSTING@Mn to achieve a potent antitumor immunity (Figure 2A).